Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
STELLA: Relacorilant and Nab-Paclitaxel in Advanced Cervical Cancer
NCT07763496Phase 2Not yet recruiting
- Sponsor
- ARCAGY
- Start
- Oct 2026
- Primary completion
- Dec 2030
- Countries
- 1
01
Overview
A Phase 2 trial of relacorilant in Cervical Cancer (CC), sponsored by ARCAGY. Planned start Oct 2026; status: not yet recruiting.
02
Drugs
relacorilant
03
Conditions
Cervical Cancer (CC)
Beyond the preview
Go deeper on NCT07763496.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07763496.